The National Institute for Health and Care Excellence (NICE) have this morning issued new guidance for the treatment of brain tumour patients. 

NICE has said a chemical dye, which can assist neurosurgeons in the successful removal of a brain tumour, should be used in initial surgery. 

Other recommendations include:

• Use targeted radiotherapy to reduce the risk of damage to the rest of the brain.
• Encourage referral to neurological rehabilitation assessment of physical, cognitive, and emotional function during all stages of treatment.
• The NHS should not offer tumour treating fields (TTF) as part of management of recurrent high-grade glioma because they are not cost effective.